Frequency and progression of azotemia during acute and chronic treatment of congestive heart failure in cats
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.17254 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2025. Written by Sarah Rogg and 6 co-authors. Institution: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, USA. Major MEDLINE topics: Azotemia, Cat Diseases, Heart Failure, Furosemide. Cited 10 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Open access funding provided by the Iowa State University Library..
Topics: Herzinsuffizienz
Abstract (original language)
Background
Azotemia is common in cats with congestive heart failure (CHF) and might be exacerbated by diuretic therapy. Hypothesis/Objectives Determine frequency, risk factors, and survival impact of progressive azotemia in cats treated for CHF. Animals One hundred and sixteen client-owned cats with kidney function testing performed at least twice during acute or chronic CHF treatment.
Methods
Serum creatinine (sCr) and electrolyte concentrations were determined at multiple clinical timepoints to detect azotemia and kidney injury (KI; sCr increase ≥0.3 mg/dL). Furosemide dosage between timepoints was calculated. Multivariable modeling was performed to identify predictors of KI, change in serum biochemistry results, and survival.
Results
Azotemia was common at all timepoints, including initial CHF diagnosis (44%). Kidney injury was documented in 66% of cats. Use of a furosemide continuous rate infusion was associated with increased risk of KI during hospitalization (odds ratio, 141.6; 95% confidence interval [CI], 12.1-6233; P = .01). Higher furosemide dosage was associated with increase in sCr during hospitalization (P = .03) and at first reevaluation (P = .01). Treatment with an angiotensin converting enzyme inhibitor was associated with fewer lifetime KI events (P = .02). Age in years was the only variable associated with shorter survival (hazard ratio, 1.1; 95% CI, 1.0-1.1; P = .03). Neither sCr nor KI were associated with long-term outcome. Conclusions and Clinical Importance Azotemia and KI were common in cats during CHF treatment but did not impact survival.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, USA.
- SMART Pharmacology, Precision One Health Initiative, Department of Veterinary Pathology, University of Georgia, Athens, Georgia, USA.
- Department of Statistics, Iowa State University, Ames, Iowa, USA.
- Department of Veterinary Clinical Sciences, University of Minnesota, Saint Paul, Minnesota, USA.
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
ORCID profiles: Debosmita Kundu, Melissa A Tropf, Darcy B Adin, Jessica L Ward
Funding
- Open access funding provided by the Iowa State University Library.
Cite
APA
Rogg, S., Mochel, J. P., Kundu, D., Tropf, M. A., Masters, A. K., Adin, D. B., & Ward, J. L. (2025). Frequency and progression of azotemia during acute and chronic treatment of congestive heart failure in cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17254
Vancouver
Rogg S, Mochel JP, Kundu D, Tropf MA, Masters AK, Adin DB, et al. Frequency and progression of azotemia during acute and chronic treatment of congestive heart failure in cats. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17254
BibTeX
@article{Rogg2025,
author = {Rogg, Sarah and Mochel, Jonathan P and Kundu, Debosmita and Tropf, Melissa A and Masters, Allison K and Adin, Darcy B and Ward, Jessica L},
title = {Frequency and progression of azotemia during acute and chronic treatment of congestive heart failure in cats},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.17254}
}
EUVIMED